Johan Spetz

14PUBLICATIONS
117CO-AUTHORS
HaematologyRadiation therapyMolecular targetsTumour immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 08, 2026
Platelet aging and desialylation increase apoptotic priming and BCL-X<sub>L</sub> dependence.

Renata Grozovsky, Cameron S Fraser, Xingping Qin

|Aug 12, 2025
Late apoptotic effects after treatment with <sup>177</sup>Lu-octreotate in small-intestine neuroendocrine GOT1 tumor model.

Mikael Elvborn, Nishte Rassol, Daniella Pettersson

|Feb 19, 2025
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.

Veronica Rendo, Eudocia Q Lee, Connor Bossi

|Jul 20, 2023
Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX.

Rumani Singh, Stacey Yu, Marwa Osman

|Jan 12, 2023
Targeting TBK1 to overcome resistance to cancer immunotherapy.

Yi Sun, Or-Yam Revach, Seth Anderson

|Nov 09, 2022
Heightened apoptotic priming of vascular cells across tissues and life span predisposes them to cancer therapy-induced toxicities.

Johan K E Spetz, Mary H C Florido, Cameron S Fraser

Pageof 3

Frequent Collaborators

8 joint publications

Kristopher A Sarosiek

6 joint publications

Xingping Qin

4 joint publications

Cameron S Fraser

2 joint publications

Aaron N Hata